Exclusive: U.S. prosecutors probe a politically explosive tip that Pfizer in 2020 delayed announcing a successful Covid-19 vaccine until after the election that Trump lost to Biden.

The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...

As the respiratory syncytial virus (RSV) vaccine ... of Pfizer’s RSV vaccine in the U.S. Meanwhile, the two companies still appear to be locked in a patent battle around mRNA COVID vaccine ...

GSK has also sued Pfizer for patent infringement in the U.S. over technology in Pfizer's blockbuster COVID-19 vaccine Comirnaty. That case is still ongoing.

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...

Still, a full approval—such as those granted to Pfizer and Moderna’s mRNA-based COVID vaccines in 2021 and 2022, respectively—would allow Novavax’s shot to stick around long-term in the ...

Moderna – at the moment embroiled in a patent dispute with Pfizer and BioNTech over mRNA intellectual property – is also testing a vaccine that combines COVID-19 and flu in a single jab in a ...

Where can I buy a Covid vaccine and what does it cost? A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The cost per single ...

Researchers from Agency for Science, Technology and Research in Singapore recently published a review article exploring how ...

Pfizer isn't a great pick for growth investors, although its growth prospects are better than some might think. The stock is a good fit for value investors, though, with its low forward earnings ...